Send Us a Message

Tell us about your organization and how we might work together. We respond to all inquiries within two business days.

Research Collaboration

We actively seek research partnerships with academic institutions, medical centers, and biotechnology companies. If you're working on problems where medical AI could contribute, we'd like to hear from you.

Research Inquiries research@ebovir.ai

Technical & Partnership

For technical discussions about our platforms, partnership opportunities, or pilot project inquiries.

Partnership Inquiries partnerships@ebovir.ai

Connect Online

Follow our work and connect with us on professional platforms.

Collaboration Opportunities

Different models for engaging with Ebovir AI based on your organization's needs.

Research Partnership

Joint research projects exploring medical AI applications. Co-development of algorithms, shared publications, and collaborative grant applications.

  • Access to AI/ML expertise
  • Joint publication opportunities
  • Shared intellectual property models
  • Grant collaboration support

Pilot Projects

Time-limited engagements to evaluate AI solutions for specific clinical or research problems. Low-risk approach to exploring medical AI capabilities.

  • Defined scope and timeline
  • Proof-of-concept development
  • Feasibility assessment
  • Clear success criteria

Platform Development

Longer-term engagements to build custom AI platforms for your organization. Full development lifecycle from requirements to deployment and support.

  • Custom solution development
  • Integration with existing systems
  • Ongoing support and maintenance
  • Training and documentation

Technical Consultation

Advisory engagements for organizations building their own medical AI capabilities. Architecture review, technology selection, and best practices guidance.

  • Architecture assessment
  • Technology recommendations
  • Best practices guidance
  • Team training options

A Note on Research Projects

We are particularly interested in research collaborations that advance the responsible development of medical AI. If you're working on problems related to clinical decision support, diagnostic AI, bioinformatics, or healthcare data systems, we welcome the opportunity to discuss potential collaboration—regardless of your organization's size or current AI capabilities.

Academic researchers, clinical investigators, and healthcare innovators are encouraged to reach out with project ideas, even at early stages.

Frequently Asked Questions

What types of organizations do you work with?

We collaborate with biotechnology companies, medical institutions, academic research centers, healthcare IT organizations, and clinical research organizations. Our focus is on partners who have genuine medical AI needs and are committed to responsible development.

How do research collaborations typically begin?

Most collaborations start with a conversation about your research goals and challenges. We then explore whether there's alignment between your needs and our capabilities, and discuss potential project structures that work for both parties.

Do you work with early-stage projects?

Yes. We're interested in research problems at various stages, from early exploration to production deployment. Early-stage discussions often lead to the most innovative collaborations.

What about data privacy and security?

Data privacy and security are fundamental to our work. We have established protocols for handling sensitive healthcare data and can work within your organization's data governance requirements. Specific arrangements are discussed for each project.

Can you work with existing systems?

Integration with existing healthcare IT systems is a core competency. We design our solutions to work within your technology environment, using standard interfaces where possible and custom integrations where necessary.

What is your approach to intellectual property?

IP arrangements vary by project type. Research collaborations often involve shared IP with publication rights. Commercial projects have different structures. We discuss IP early in any engagement to ensure alignment.